home / stock / vtrs / vtrs articles


VTRS Articles, Viatris Inc.

Stock Information

Company Name: Viatris Inc.
Stock Symbol: VTRS
Market: NASDAQ

Menu

VTRS VTRS Quote VTRS Short VTRS News VTRS Articles VTRS Message Board
Get VTRS Alerts

News, Short Squeeze, Breakout and More Instantly...

Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast | Benzinga

Thursday, Viatris Inc (NASDAQ:VTRS) reported first-quarter EPS of $0.67, which is in line with the consensus. The company reported s...

Viatris And Idorsia Forge Global Partnership For Breakthrough Heart Attack Treatments | Benzinga

On Wednesday, Viatris Inc. (NASDAQ:VTRS) said it has inked a pact with Idorsia for a significant global research and development col...

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration | Benzinga

Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selatogrel and Cenerimod, Both With Blockbuster Rev...

5 Value Stocks In The Healthcare Sector | Benzinga

The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This...

Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts | Benzinga

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...

Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today? | Benzinga

Theravance Biopharma Inc (NASDAQ: TBPH) announced results from the Phase 4 PIFR-2 study of Yupelri (revefenacin) inhalation solution, the only...

VIATRIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Viatris Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigati...

Regeneron Celebrates Legal Win: Court Upholds Eylea Medication Patent | Benzinga

Wednesday, a court ruling that found Viatris Inc's (NASDAQ: VTRS) replica of Regeneron Pharmaceuticals Inc's ...

3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Health Care Sector From Wall Street's Most Accurate Analysts | Benzinga

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...

A Look Into Healthcare Sector Value Stocks | Benzinga

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's fut...

Next 10